Indicators of a Major Depressive Episode in Primary Care Patients With a Chief Complaint of Headache

Maeno, Tetsuhiro; Inoue, Kazuo; Yamada, K; Maeno, Takami; Sato, Takeshi

doi:10.1111/j.1526-4610.2007.00775.x

Cited by 10 publications

(10 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, validated screening instruments, such as the Patient Health Questionnaire 55 and the Insomnia Severity Index, 56 can be easily administered to MOH patients by primary care physicians to identify depressive symptoms and insomnia. 27,[57][58][59] Thus, early and comprehensive assessment of these risk factors is necessary for medical and mental health professionals to consider while evaluating and treating patients with MOH to improve their quality of life.…”

Section: Discussionmentioning

confidence: 99%

Depression and insomnia are independently associated with satisfaction and enjoyment of life in medication-overuse headache patients

Pompili¹,

Innamorati

Lamis

et al. 2016

Int J Psychiatry Med

View full text Add to dashboard Cite

Objective Medication-overuse headache is often comorbid with emotional disturbances and disordered personality traits. The aim of the present study was to determine whether depression and insomnia complaints were associated with satisfaction and enjoyment with one's own life in medication-overuse headache patients, and whether insomnia complaints were able to explain part of the variance of Quality of Life explained by depression. Methods Participants were 187 consecutive adult outpatients admitted to the Regional Referral Headache Centre of the Sant'Andrea Hospital in Rome, Italy. Patients were administered the Quality of Life Enjoyment and Satisfaction Questionnaire, the Beck Depression Inventory - II, and the Athens Insomnia Scale. Results The Beck Depression Inventory was associated with all the dimensions of the Quality of Life Enjoyment and Satisfaction Questionnaire, with more severe depression being associated independently with lower satisfaction and enjoyment with one's own life. The Athens Insomnia Scale was independently and significantly associated only with physical health, such that patients with more insomnia complaints were 3.1 times ( p < 0.001) more likely to report lower physical health satisfaction. Conclusions Our findings confirmed that medication-overuse headache patients has a negative impact on quality of life and suggested that depression and insomnia were independently associated with satisfaction and enjoyment of life in medication-overuse headache patients. The early recognition and appropriate treatment of comorbid psychopathological symptoms are crucial to improve satisfaction and enjoyment of life in medication-overuse headache patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Depression and insomnia are independently associated with satisfaction and enjoyment of life in medication-overuse headache patients

Pompili¹,

Innamorati

Lamis

et al. 2016

Int J Psychiatry Med

View full text Add to dashboard Cite

show abstract

“…reported a prevalence of 25.4% major depressive episodes in primary care patients with a chief complaint of headache. [ 10 ] However, other depression subtypes were not assessed. Another case-control study found that 32% of primary care patients with a chief complaint of headache were diagnosed with a major depressive disorder.…”

Section: Discussionmentioning

confidence: 99%

“…In contrast, Maeno et al . [ 10 ] reported that headache duration predicts a higher risk for a major depressive episode. Our study added another perspective regarding the relationship between headache duration and episodes of a psychiatric disorder.…”

Section: Discussionmentioning

confidence: 99%

“…[ 9 ] reported that nearly one-third of patients who present to primary care offices with a complaint of headache have moderate depression, 25.4% of patients with headache visiting a primary care setting fulfilled the diagnostic criteria for a major depressive episode. [ 10 ] Nimnuan et al . [ 11 ] found that the prevalence rates of depression and anxiety are 29.2% and 9.7%, respectively, in patients with headache in a tertiary care facility.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Overlap between Headache, Depression, and Anxiety in General Neurological Clinics

Wei

Jia

Wang

et al. 2016

Chinese Medical Journal

View full text Add to dashboard Cite

Background:Many studies have reported that depression and anxiety have bidirectional relationship with headache. However, few researches investigated the roles of depression or anxiety in patients with headache. We surveyed the prevalence of depression and anxiety as a complication or cause of headache among outpatients with a chief complaint of headache at neurology clinics in general hospitals. Additional risk factors for depression and anxiety were also analyzed.Methods:A cross-sectional study was conducted at 11 general neurological clinics. All consecutive patients with a chief complaint of headache were enrolled. Diagnoses of depression and anxiety were made using the Chinese version of the Mini International Neuropsychiatric Interview, and those for headache were made according to the International Classification of Headache Disorders, 2nd Edition. The headache impact test and an 11-point verbal rating scale were applied to assess headache severity and intensity. Logistic regression was used to analyze risk factors of patients with headache for depression or anxiety.Results:A total of 749 outpatients with headache were included. Among them, 148 (19.7%) were diagnosed with depression and 103 (13.7%) with anxiety. Further analysis showed that 114 (15.2%) patients complaining headache due to somatic symptoms of psychiatric disorders and 82 (10.9%) had a depression or anxiety comorbidity with headache. Most patients with depression or anxiety manifested mild to moderate headaches. Poor sleep and severe headache-related disabilities were predictors for either depression or anxiety.Conclusion:Clinicians must identify the etiology of headache and recognize the effects of depression or anxiety on headache to develop specific treatments.

show abstract

“…The possible reason for higher rates of undiagnosed neurological disorders (migraine headache and epilepsy) might be due to a significant overlap between symptoms of severe psychiatric disorder and neurological disorders. For instance, a study conducted by Moeno et.al found that more than one fourth (25.4%) of patients with major depressive disorders visited a primary care setting with a chief complaint of headache [48]. Similarly, a case-control study conducted by Marlow et.al reported that 32% of patients who reported headaches as the main symptoms were diagnosed with major depressive disorders [49].…”

Section: The Prevalence Of Undiagnosed Neurological Disorders Diseasementioning

confidence: 99%

Prevalence and correlates of diagnosed and undiagnosed epilepsy and migraine headache among people with severe psychiatric disorders in Ethiopia

Ayano

Demelash

Yohannes³

et al. 2020

PLoS ONE

View full text Add to dashboard Cite

Background There is a paucity of research on the prevalence of diagnosed as well as undiagnosed neurological disorders with episodic manifestations such as epilepsy and migraine headaches in people with severe psychiatric disorders (SPD). To the best of our knowledge, this is the first study analyzing and comparing the prevalence of diagnosed and undiagnosed chronic neurological disorders with episodic manifestations including epilepsy and migraine headache in people with SPD. Method This quantitative cross-sectional survey was undertaken among 309 patients with SPD selected by a systematic random sampling technique. The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) was used to confirm SPD among the participants. The International Classification of Headache Disorders (ICHD-3) and International League Against Epilepsy (ILAE) were used to define migraine headache and epilepsy, respectively]. Risk factors for chronic neurologic disorders were explored by using logistic regression models. Result In this study, the prevalence of overall neurological disorders, epilepsy, and migraine headache among people with SPD were found to be 5.2% (95%CI 3.2–8.3), 1.6% (95%CI 0.7–3.9), and 3.9% (95%CI 2.2–6.7), respectively. We found that a considerably higher proportion of people with SPD had undiagnosed overall neurological disorder (87.5%; 14/16), epilepsy (60%; 3/5), as well as migraine headaches (100%; 12/12). On the other hand, in this study, 12.5%, 40%, and 0% of patients with overall neurologic disorder, epilepsy, and migraine headaches respectively were diagnosed by the professionals. Higher disability score (WHODAS score) was associated with increased odds of having neurological disorders compared with the lower WHODAS score [OR = 1.30 (95% CI 1.02–1.66)]. Conclusion Whilst the prevalence estimates of neurological disorders with episodic manifestations including epilepsy and migraine headache was high among people with SPD, the vast majority of them remained undiagnosed. The diagnosis rates of those disorders were significantly low, perhaps surprisingly zero for migraine headache. High WHODAS score was associated with increased odds of having neurological disorders. Routine screening and management of epilepsy and migraine headache are imperative among people with SPD.

show abstract

Indicators of a Major Depressive Episode in Primary Care Patients With a Chief Complaint of Headache

Cited by 10 publications

References 26 publications

Depression and insomnia are independently associated with satisfaction and enjoyment of life in medication-overuse headache patients

Depression and insomnia are independently associated with satisfaction and enjoyment of life in medication-overuse headache patients

Overlap between Headache, Depression, and Anxiety in General Neurological Clinics

Prevalence and correlates of diagnosed and undiagnosed epilepsy and migraine headache among people with severe psychiatric disorders in Ethiopia

Contact Info

Product

Resources

About